Characteristics of patients with psoriasis with Psoriasis Area and Severity Index < 10 treated with biological agents : results from the French PsoBioTeq cohort
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:185 |
|---|---|
| Enthalten in: |
The British journal of dermatology - 185(2021), 5 vom: 15. Nov., Seite 1052-1054 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Beylot-Barry, M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 07.12.2021 Date Revised 14.12.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/bjd.20585 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM326762604 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM326762604 | ||
| 003 | DE-627 | ||
| 005 | 20231225195310.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bjd.20585 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1089.xml |
| 035 | |a (DE-627)NLM326762604 | ||
| 035 | |a (NLM)34128543 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Beylot-Barry, M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Characteristics of patients with psoriasis with Psoriasis Area and Severity Index < 10 treated with biological agents |b results from the French PsoBioTeq cohort |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.12.2021 | ||
| 500 | |a Date Revised 14.12.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Biological Factors |2 NLM | |
| 650 | 7 | |a Biological Products |2 NLM | |
| 700 | 1 | |a Seneschal, J |e verfasserin |4 aut | |
| 700 | 1 | |a Tran, D |e verfasserin |4 aut | |
| 700 | 1 | |a Bachelez, H |e verfasserin |4 aut | |
| 700 | 1 | |a Beneton, N |e verfasserin |4 aut | |
| 700 | 1 | |a Dupuy, A |e verfasserin |4 aut | |
| 700 | 1 | |a Joly, P |e verfasserin |4 aut | |
| 700 | 1 | |a Jullien, D |e verfasserin |4 aut | |
| 700 | 1 | |a Mahé, E |e verfasserin |4 aut | |
| 700 | 1 | |a Paul, C |e verfasserin |4 aut | |
| 700 | 1 | |a Richard, M-A |e verfasserin |4 aut | |
| 700 | 1 | |a Sbidian, E |e verfasserin |4 aut | |
| 700 | 1 | |a Viguier, M |e verfasserin |4 aut | |
| 700 | 1 | |a Chosidow, O |e verfasserin |4 aut | |
| 700 | 1 | |a Tubach, F |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The British journal of dermatology |d 1951 |g 185(2021), 5 vom: 15. Nov., Seite 1052-1054 |w (DE-627)NLM000000361 |x 1365-2133 |7 nnns |
| 773 | 1 | 8 | |g volume:185 |g year:2021 |g number:5 |g day:15 |g month:11 |g pages:1052-1054 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/bjd.20585 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 185 |j 2021 |e 5 |b 15 |c 11 |h 1052-1054 | ||